- Home
- EHC
EHC
Encompass Health Corporation
as 04-25-2025 4:00pm EST
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | BIRMINGHAM |
| Market Cap: | N/A | IPO Year: | 1986 |
| Target Price: | $111.00 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.84 | EPS Growth: | 30.44 |
| 52 Week Low/High: | $82.09 - $114.37 | Next Earning Date: | 04-24-2025 |
| Revenue: | $5,512,600,000 | Revenue Growth: | 11.21% |
| Revenue Growth (this year): | 10.1% | Revenue Growth (next year): | 8.65% |
Stock Insider Trading Activity of Encompass Health Corporation (EHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Price Andrew L | EHC | Chief Accounting Officer | Feb 13 '25 | Sell | $98.29 | 5,042 | $495,578.18 | 69,164 |
Latest Encompass Health Corporation News
EHC Breaking Stock News: Dive into EHC Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Here's What Key Metrics Tell Us About Encompass Health (EHC) Q1 Earnings
Zacks
a day ago
Encompass Health (EHC) Surpasses Q1 Earnings and Revenue Estimates
StockStory
a day ago
Encompass Health (NYSE:EHC) Posts Better-Than-Expected Sales In Q1
MT Newswires
a day ago
Encompass Health Q1 Earnings, Revenue Rise; Ups Guidance
Associated Press Finance
a day ago
Encompass Health: Q1 Earnings Snapshot
PR Newswire
a day ago
Encompass Health announces promotion of Patrick Tuer to newly established COO position
PR Newswire
a day ago
Encompass Health reports results for first quarter 2025
Zacks
2 days ago
Amedisys (AMED) Tops Q1 Earnings Estimates
Compare EHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EHC Encompass Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.